Similarly, another study of osteosarcomas did not show prognostic significance for CD8 infiltration in the whole cohort, but it was found to be a positive prognostic factor for patients treated with an osteoclast inhibitor [22]. The gene discussed is CD8A; the disease is osteosarcoma.